Position in HOWL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$31,266
-$41,080 QoQ
Shares Held
86,851
0.0% QoQ
Ownership
0.179%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 45 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HOWL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. HOWL ranks #397 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in HOWL
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,266 | 86,851 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $72,346 | 86,851 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $55,063 | 86,851 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $129,696 | 65,836 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $71,761 | 65,836 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $251,220 | 258,458 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $361,697 | 244,390 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $482,829 | 227,750 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $142,979 | 58,598 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $314,292 | 48,502 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $191,641 | 49,648 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $55,783 | 26,067 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $79,504 | 26,067 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $51,755 | 19,906 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $37,799 | 18,439 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $83,673 | 18,553 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $56,514 | 13,818 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $858,298 | 195,068 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,382,773 | 200,065 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,208,131 | 70,404 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,321,497 | 75,774 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||